ERG and prostate carcinoma: Gene rearrangements in SLC45A3 were concurrent with ERG rearrangements in a prostate cancer cohort [64], with SLC45A3-ERG gene re-arrangement associated with loss of SLC45A3 protein expression and an unfavorable clinical course in prostate cancers [65].